<DOC>
	<DOCNO>NCT02030015</DOCNO>
	<brief_summary>The investigator hypothesize combination therapy use miglustat ketogenic diet infantile juvenile patient gangliosidoses create synergy 1 ) improve overall survival patient infantile juvenile gangliosidoses , 2 ) improve neurodevelopmental clinical outcome therapy , compare data report previous natural history study . The ketogenic diet indicate management seizure patient seizure disorder . In study , ketogenic diet use minimize prevent gastrointestinal side-effects miglustat . A Sandhoff disease mouse study show ketogenic diet may also improve central nervous system response miglustat therapy ( see Denny `` Citations '' list ) . Patients infantile juvenile gangliosidoses commonly suffer seizure disorder , use ketogenic diet patient may therefore also improve seizure management .</brief_summary>
	<brief_title>Synergistic Enteral Regimen Treatment Gangliosidoses</brief_title>
	<detailed_description>The infantile juvenile form GM1 GM2 gangliosidoses neurodegenerative condition lethal childhood . There know effective therapy available treatment infantile juvenile gangliosidoses . Studies monotherapy miglustat treatment condition demonstrate safety , demonstrate notable clinical improvement . To date , combination therapy infantile juvenile gangliosidoses explore . This study evaluate multi-targeted combination therapy treatment gangliosidoses , use FDA approve therapy demonstrate safety child . It aim study learn combination therapy use `` Syner-G '' regimen ( , synergistic enteral regimen treatment gangliosidoses ) show improvement overall survival clinical benefit neurodevelopmental ability child gangliosidosis diseases . This study plan 5-year longitudinal treatment study . Subjects start treatment regimen enrol study . Data collect yearly evaluation completion study . Investigators may choose stop therapy time , clinically indicate individual patient . The Ketogenic Diet special diet contain high amount fat low amount carbohydrate compare average diet . The purpose help reduce food-miglustat interaction . The ketogenic diet may also help management seizure patient . ( The ketogenic diet use anti-seizure treatment variety medical condition many decade . ) A study Sandhoff disease mouse show ketogenic diet may also help miglustat effective central nervous system ( see Denny `` Citations '' list ) . Miglustat use reduce amount ganglioside accumulation child 's cell . Miglustat FDA approve treatment gangliosidoses . It FDA approve different inherit metabolic disease call Gaucher disease type I . This study issue Investigational New Drug ( IND ) # 127636 U.S. Food Drug Administration ( FDA ) .</detailed_description>
	<mesh_term>Gangliosidoses</mesh_term>
	<mesh_term>Tay-Sachs Disease</mesh_term>
	<mesh_term>Sandhoff Disease</mesh_term>
	<mesh_term>Gangliosidoses , GM2</mesh_term>
	<mesh_term>Gangliosidosis , GM1</mesh_term>
	<mesh_term>Miglustat</mesh_term>
	<mesh_term>1-Deoxynojirimycin</mesh_term>
	<criteria>1 . Subjects must document infantile juvenile gangliosidosis disease . 2 . Age : 17 year less time enrollment 3 . Subjects caregiver must willing work ketogenic diet team management subject 's ketogenic diet . 1 . A desire participate 2 . Patients older 17 year enrol study . 3 . Children severe renal impairment enrol study . 4 . Postpubertal female pregnant , unwilling use highlyeffective method prevent pregnancy , exclude study . 5 . Breastfeeding female exclude study . 6 . Subjects allergy miglustat component within drug product exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>204 Months</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>infantile Tay-Sachs disease</keyword>
	<keyword>juvenile Tay-Sachs disease</keyword>
	<keyword>infantile GM1 gangliosidosis</keyword>
	<keyword>juvenile GM1 gangliosidosis</keyword>
	<keyword>infantile GM2 gangliosidosis</keyword>
	<keyword>juvenile GM2 gangliosidosis</keyword>
	<keyword>Sandhoff disease</keyword>
	<keyword>gangliosidoses</keyword>
	<keyword>miglustat</keyword>
	<keyword>ketogenic diet</keyword>
	<keyword>SYNER-G regimen</keyword>
	<keyword>Syner-G</keyword>
	<keyword>Zavesca</keyword>
	<keyword>Tay-Sachs disease</keyword>
	<keyword>Tay Sachs disease</keyword>
</DOC>